It appears that the role of E2 in CRC progression is complicated by the relative expression of the different estrogen-ligand receptors and GPER under varying ambient oxygen tension and is not simply, as previously suggested, to be a unique protective effect through ERβ activation. This evidence concerns the gene GPER1 and colorectal carcinoma.